Reduced MyD88 dependency of ISCOMATRIX™ adjuvant in a DNA prime-protein boost HIV vaccine
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced MyD88 dependency of ISCOMATRIX™ adjuvant in a DNA prime-protein boost HIV vaccine
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 10, Issue 4, Pages 1078-1090
Publisher
Informa UK Limited
Online
2014-02-11
DOI
10.4161/hv.27907
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum Cytokine Profiles Associated with Specific Adjuvants Used in a DNA Prime-Protein Boost Vaccination Strategy
- (2013) Rachel Buglione-Corbett et al. PLoS One
- Genomic responses in mouse models poorly mimic human inflammatory diseases
- (2013) Junhee Seok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope
- (2012) M. S. de Souza et al. JOURNAL OF IMMUNOLOGY
- ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases
- (2012) A. Baz Morelli et al. JOURNAL OF MEDICAL MICROBIOLOGY
- ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway
- (2011) Nicholas S Wilson et al. IMMUNOLOGY AND CELL BIOLOGY
- ISCOMATRIX Adjuvant Combines Immune Activation with Antigen Delivery to Dendritic Cells In Vivo Leading to Effective Cross-Priming of CD8+ T Cells
- (2011) P. Duewell et al. JOURNAL OF IMMUNOLOGY
- Pattern Recognition Receptors and the Innate Immune Response to Viral Infection
- (2011) Mikayla R. Thompson et al. Viruses-Basel
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- ISCOMATRIX™ vaccines: Safety in human clinical studies
- (2010) Andrew McKenzie et al. Human vaccines & immunotherapeutics
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity
- (2010) Michael Vaine et al. VACCINE
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
- (2009) Fiona A. Sharp et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multifunctional T-Cell Characteristics Induced by a Polyvalent DNA Prime/Protein Boost Human Immunodeficiency Virus Type 1 Vaccine Regimen Given to Healthy Adults Are Dependent on the Route and Dose of Administration
- (2008) A. Bansal et al. JOURNAL OF VIROLOGY
- The habitual, diverse and surmountable obstacles to human immunology research
- (2008) Adrian C Hayday et al. NATURE IMMUNOLOGY
- Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers
- (2008) Shixia Wang et al. VACCINE
- The safety and tolerability of an HIV-1 DNA prime–protein boost vaccine (DP6-001) in healthy adult volunteers
- (2008) Jeffrey S. Kennedy et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now